Psychiatric adverse reactions with statins, fibrates and ezetimibe: Implications for the use of lipid-lowering agents

Drug Safety

Volumn 30, Issue 3, 2007, Pages 195-201

  Tatley, Michael ^a   Savage, Ruth ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXAPINE; ANTILIPEMIC AGENT; ATORVASTATIN; BEZAFIBRATE; CHOLESTEROL; CLOFIBRATE; EZETIMIBE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LITHIUM; ORPHENADRINE; PRAVASTATIN; SIMVASTATIN; TRIFLUOPERAZINE; WARFARIN;

ABNORMAL THINKING; AGGRESSION; AGITATION; AMNESIA; ANXIETY; ASTHENIA; BRAIN CELL; COMPULSION; CONFUSION; DEPERSONALISATION; DEPRESSION; DISORIENTATION; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG WITHDRAWAL; EUPHORIA; FATIGUE; HALLUCINATION; HUMAN; INSOMNIA; IRRITABILITY; LETHARGY; MALAISE; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DISEASE; MENTAL INSTABILITY; NERVOUSNESS; NIGHTMARE; PANIC; PARANOIA; PARONIRIA; PERCEPTION DISORDER; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOMNOLENCE; SUICIDE ATTEMPT;

EID: 33947247905     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730030-00003     Document Type: Review

References (21)

1. Hebert PR, Gaziano JM, Chan KS, et al. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA 1997 Jul 23-30; 278 (4): 313-21
2. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke: a meta-analysis of randomized, controlled trials. Ann Intern Med 1998 Jan 15; 128 (2): 89-95
3. Orsi A, Sherman O, Woldeselassie Z. Simvastatin-associated memory loss. Pharmacotherapy 2001 Jun; 21 (6): 767-9
4. Scott HD, Laake K. Statins for the reduction of risk of Alzheimer's disease. Cochrane Database Syst Rev 2001 (3): CD003160
5. Golomb BA, Kane T, Dimsdale JE. Severe irritability associated with statin cholesterol-lowering drugs. QJM 2004 Apr; 97 (4): 229-35
6. Simons J. The $10 billion pill. Fortune. 2003 Jan 20; 147 (1): 58-62
7. Davidson MH. Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust. Drugs 2001; 61 (2): 197-206
8. Charatan F. Bayer decides to withdraw cholesterol lowering drug. BMJ 2001 Aug 18; 323 (7309): 359
9. Savage R, Tatley M. Myopathy with statins: check CK levels and interactions. Prescriber Update 2004 May; 25 (1): 4-5
10. Golomb BA, Criqui MH, White H, et al. Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Arch Intern Med 2004 Jan 26; 164 (2): 153-62
11. Gaist D, Jeppesen U, Andersen M, et al. Statins and risk of polyneuropathy: a case-control study. Neurology 2002 May 14; 58 (9): 1333-7
12. Wagstaff LR, Mitton MW, Arvik BM, et al. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 2003 Jul; 23 (7): 871-80
13. King DS, Wilburn AJ, Wofford MR, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003 Dec; 23 (12): 1663-7
14. Muldoon MF, Ryan CM, Sereika SM, et al. Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 2004 Dec 1; 117 (11): 823-9
15. Manfredini R, Caracciolo S, Salmi R, et al. The association of low serum cholesterol with depression and suicidal behaviours: new hypotheses for the missing link. J Int Med Res 2000 Nov-Dec; 28 (6): 247-57
16. Vevera J, Fisar Z, Kvasnicka T, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res 2005 Feb 28; 133 (2-3): 197-203
17. Golomb BA, Stattin H, Mednick S. Low cholesterol and violent crime. J Psychiatr Res 2000 Jul-Oct; 34 (4-5): 301-9
18. Golomb BA. Cholesterol and violence: is there a connection? Ann Intern Med 1998 Mar 15; 128 (6): 478-87
19. Saheki A, Terasaki T, Tamai I, et al. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res 1994 Feb; 11 (2): 305-11
20. Engelberg H. Low serum cholesterol and suicide. Lancet 1992 Mar 21; 339 (8795): 727-9
21. Wardle J, Rogers P, Judd P, et al. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am J Med 2000 May; 108 (7): 547-53